Dec 2021; Probant medicamenta sequentia ad curationem cancri hepatis. Quaeso reprehendo praescribit priusquam medicamento.
Atezolizumab
Avastin (Bevacizumab)
Bevacizumab
Cabometyx (Cabozantinib-S-Malate)
Cabozantinib-S-Malate
Cyramza (Ramucirumab)
Infigratinib Phosphate
Keytruda (Pembrolizumab)
Lenvatinib Mesylate
Lenvima (Lenvatinib Mesylate)
Nexavar (Sorafenib Tosylate)
Nivolumab
Opdivo (Nivolumab)
Pemazyre (Pemigatinib)
Pembrolizumab
Pemigatinib
Ramucirumab
Regorafenib
Sorafenib Tosylate
Stivarga (Regorafenib)
Tecentriq (Atezolizumab)
Truseltiq (Infigratinib Phosphate)
